Clinical Trials
3 trialsNCT05006196 2026-05-20
IMOGEN
Perspectum
Active not recruiting
NCT05755269 2026-05-01
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
Mayo Clinic
Terminated
NCT06534424 2025-06-27
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
Ohio State University Comprehensive Cancer Center
Phase NA Completed